H.R. 3156 To Tighten Supplement Safety Rules - But Why Only Supplements?
June 30, 2005 - Representative Susan Davis has introduced House Resolution 3156, also called the "Dietary Supplement Access and Awareness Act". The bill is co-sponsored by John Dingell and Henry Waxman and requires constant notification of new supplements put on the market, similar to the notification introduced by the European Food Supplements Directive.
The stricter rules, which echo a previous bill (H.R. 3377) are directed at supplements that contain herbs and herbal extracts as well as any other substances that are not strictly vitamins and minerals. In an apparent attempt to pre-empt a recent court ruling that held ephedra may be sold as long as the dose is lower than 10 mg, the bill authorizes the Secretary of Health and Human Services to require reports of adverse events and to determine the fate of any supplement by assessing the risks against the benefits.
Even a small risk may lead to removal of a supplement from the market, as it would be up to the Secretary to assess whether there is sufficient benefit. In a sane world, this would be acceptable, but the trouble is that the FDA usually acts to remove a whole class of supplements, regardless of dose, source of the ingredient or combination with other ingredients. This happened with ephedra, leading to a de-facto complete ban of any supplement containing the herb. Except, of course, prescription and over-the-counter medicines that contain the extract, and that, in my book, is an unjustifiable double standard. The Secretary is also directed by the bill and given funding to promote the reporting of side effects.
Now if supplements are to be evaluated, controlled and taken off the market at the first hint of trouble, I would like to see the same treatment be reserved to food additives, such as aspartame, and to pharmaceutical drugs that have been shown to kill people by the thousands routinely as well as any other things we routinely ingest, be they foods, drinks or meds.
While it is quite reasonable to demand supplements be safe, why not demand that food additives and medicines be just as safe? And why not start with the ones that have shown the biggest safety problems? Perhaps the Davis-Dingell-Waxmann bill should be extended to cover not only supplements but all the substances we routinely ingest. We could then prioritize intervention where it serves most.
According to the statistics compiled by Ron Law, risk analysis expert and policy analyst from New Zealand, supplements are the absolutely safest category of products in existence. I would certainly welcome all other ingestable products be brought to the same level of safety.
Here is a call for action issued by the Weston A. Price Foundation, forwarded by Chris Gupta of "Share the Wealth":
- - -
WESTON A. PRICE FOUNDATION
ACTION ALERT
July 25, 2005TAKE ACTION TO DEFEAT HR 3156, LIMITING AVAILABILITY OF DIETARY SUPPLEMENTS
We need your help to put the brakes on a bad bill in the U.S. House of Representatives. H.R. 3156, otherwise known as the Dietary Supplement Access and Awareness Act, would give the FDA authority to ban virtually any herb or specialty product from the market if it failed to pass an arbitrary risk/benefit analysis.
H.R. 3156 threatens to fundamentally alter DSHEA (the Dietary Supplement Health & Education Act.) DSHEA allows you to purchase dietary supplements while giving the Food and Drug Administration authority to remove unsafe products from the market.
H.R. 3156 would hold dietary supplements to a higher standard than riskier food additives and over-the-counter drugs. It proposes onerous and unnecessary reporting requirements that will increase the cost of your medicinal herbs without providing a safer product. It also establishes a troubling risk analysis process that could remove any dietary supplement even if there is no proof of actual harm.
According to the language of H.R. 3156, an herb should be removed from the market if there is any chance of a so-called risk unless "sufficient" health benefits are proved to the FDA's satisfaction. This approach ignores the bio-individuality of individuals and is an impossible standard for most supplement manufacturers to meet; the science in this area receives less than 1% of U.S. research funding.
This bill is unacceptable and if allowed to progress will severely undermine your health rights. Take action today! And tell your friends. Together, we can put the brakes on this bill that is bad for health, bad for you, and bad for the nation's pocketbook.
Please go to this link to ask your Congressperson to vote NO on this bill:
Thank you.*********************************************************
Bill Sanda
Executive Director
Weston A. Price Foundation
bsanda@westonaprice.orgOur postal address is
PMB #106-380
4200 Wisconsin Avenue, NW
Washington, District of Columbia 20016
United States
See also:New Bill Targets Herbal Supplements
Silver Spring, MD -- (NATURALWIRE) -- US Representative Susan Davis (D-CA) has introduced a bill that proposes to revise the "unreasonable risk” clause of DSHEA by significantly altering FDA's burden of proving that an ingredient is unsafe for use in dietary supplements.
posted by Sepp Hasslberger on Tuesday July 26 2005
updated on Monday December 13 2010URL of this article:
http://www.newmediaexplorer.org/sepp/2005/07/26/hr_3156_to_tighten_supplement_safety_rules_but_why_only_supplements.htm
Related ArticlesGlobalizing Health - Documentary Exposes Codex, FDA, WTO Agenda
I just watched a documentary, produced by Kevin Miller, that takes up the subject of international health legislation, as promoted by the European Union, Codex Alimentarius, the FDA and other, lesser players. "We become silent" is the first comprehensive effort to bring together testimony and information about an ongoing battle for health freedom. Under the pretext of "protecting consumers", international rules are being put into effect, first in Europe but... [read more]
June 29, 2005 - Sepp HasslbergerEli Lilly Knew Prozac Causes Suicides, Violence - FDA Closed Both Eyes
Prozac, called fluoxetine by generic name, is a psychiatric drug prescribed to over 50 million people including millions of children. The drug was linked to increased suicides and violence as early as 1988, in a recently emerged document. Apparently the evaluation was known to Prozac's maker Eli Lilly as early as the 'eighties, but was never even given to the FDA. This is the preoccupying picture that emerged just days... [read more]
January 01, 2005 - Sepp HasslbergerVioxx Shows: FDA Unable To Protect Public From Deadly Medical Drugs
According to recent congressional testimony, "the FDA as currently configured is incapable of protecting America against another Vioxx. We are virtually defenceless," said David Graham, associate director of the agency's Office of Drug Safety. The quote is from an article published in South Africa, titled Doctor: FDA is too cosy with drug firms. The FDA is the national food and medicines regulatory agency of the US but it has been... [read more]
November 23, 2004 - Sepp HasslbergerFDA - Monsanto: dangerous relations
Monsanto Corporation has been aggressively developing and pushing genetically modified seeds and their logical toxic counterpart, Roundup herbicide, now less damaging for some superweeds that have learned to survive the toxic onslaught by accepting genes from their GM cousins. The company has also developed a widely sold sweetener - Aspartame - which, has been called toxic by a number of researchers and according to some, is implicated in an epidemic... [read more]
November 30, 2003 - Sepp HasslbergerFDA bans Ephedra: deaths may be Aspartame related
The FDA has announced a ban on Ephedra, a herb that has been used in different remedies for millennia and that more recently has been sold as an energy booster and slimming aid. While it is quite correct that a dangerous product should be banned if the risk posed by it is - let's use the FDA's own term - "unreasonably high", I am afraid that the evaluation of the... [read more]
December 30, 2003 - Sepp HasslbergerFDA Suppressed Vital Drug Safety Information
12 June 2005 - The Independent published an article today which makes the case that vital safety information on numerous pharmaceutical products is purposely withheld by the FDA to protect the interests of pharma producers. In addition to Vioxx and the whole family of Cox-2 inhibitors, other painkillers, previously thought safe, are now found to cause similar effects on cardiac health. The data was buried and partially concealed by the... [read more]
June 12, 2005 - Sepp Hasslberger
